MedPath

Study about the influence to the gastric bleeding after the gastric endoscopic submucosal dissection (ESD) of the time to do the second-look endoscopy.

Not Applicable
Conditions
early gastric cancer, gastric adenoma
Registration Number
JPRN-UMIN000012451
Lead Sponsor
Saiseikai Yokohamashi Nanbu Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) Systemic administration of NSAIDs, corticosteroid, antiplatelet agent, or anticoagulant agent. 2) The diameter of a tumor is 5 cm or more. 3) History of gastrectomy or vagus nerve separation. 4) With the warning views on vomiting, gastrointestinal bleeding, rapid weight loss, etc. 5) With alcohol dependence or drug addiction. 6) Wit critical hormone abnormalities, such as hyperthyroidism. 7) With critical heart, liver and renal dysfunction, or a hematopoietic disorder. 8) With an allergy to medication (PPI). 9) Pregnant or lactation woman.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath